Conclusions:
Patients with a history of cancer who are hospitalized with SARS-CoV-2
infection are not at greater risk for AKI, though they are at higher
risk for mortality as compared to patients without a history of cancer.
The increased risk in mortality appears driven by patients with
pulmonary neoplasms. Patients with a history of genitourinary
malignancies do not appear to be at higher risk for AKI or for mortality
compared to the general population.